

Medtech VC through to IPO. Founded and exited 2 high-tech ventures in Bay area.
%20(1).png)
Among Top 50 Health Tech CEOs worldwide 2022.

Clinical Director of National Intestinal Failure service NZ.

Former Managing Director of Brandwood Biomedical NZ; early investor and development team member at Aroa Biosurgery.

Principal in ostomy and wound care. Led $8B medtech IPO on LSE.

Intestinal motility expert.

Viscous medical pump design & IP expert.

International clinical nutrition specialist with senior roles across leading professional societies, including the British Pharmaceutical Nutrition Group and ASPEN.

#1 chyme reinfusion expert Europe.

Experienced stomal therapist providing clinical education and hands-on support for patients using chyme reinfusion therapy across Europe.

Stomal therapy specialist with extensive experience supporting patients with enterostomies, intestinal fistulas and chyme reinfusion therapy.

Clinician-researcher specialising in postoperative gut function, gastrointestinal recovery, patient outcomes and collaborative clinical research.

Senior EU growth and channel management expert. Multiple exits.

Healthcare executive with extensive experience developing commercial strategies and launching medical and nutritional products across Europe.

MedTech commercialisation specialist with experience in human physiology, technology transfer, international sales and strategic partnerships.

Quality and regulatory specialist with more than 25 years of healthcare experience across medical-device and digital-health companies.

Develops digital systems and automation supporting production, clinical operations and business processes.
Commercialising decades of clinical experience in intestinal surgery into breakthrough medical devices
The Insides Company brings together clinical expertise, medical technology, education and international partnerships to help people recovering from severe intestinal conditions.
Our work is focused on making chyme reinfusion therapy more accessible and establishing a new standard of care.
We listen to patients, clinicians and one another so we understand the real need and act with purpose.